CN106632557A
|
|
Method for preparing nelarabine compound used for antitumor drug
|
CN106619690A
|
|
Antitumor drug nelarabine composition
|
CN106632255A
|
|
Vandetanib compound for anti-tumor medicine vandetanib composition capsule
|
CN106619641A
|
|
Composition capsule of anti-tumor medicine Vandetanib
|
CN106632556A
|
|
Nelarabine compound of nelarabine powder injection composition used for antitumor drug
|
CN106831918A
|
|
A kind of method for preparing the nelarabine compound for antineoplastic nelarabine powder-injection composition
|
CN106619642A
|
|
Composition dry suspension of anti-tumor medicine Vandetanib
|
CN106632555A
|
|
Antitumor medicine nelarabine compound
|
CN106420658A
|
|
Ceftazidime capsule for treating surgical infection
|
CN106432280A
|
|
Medicine ceftazidime crystalline compound for treating surgical operation infection
|
CN106432278A
|
|
Crystalline compound of drug ceftriaxone sodium for treating surgical operation infections
|
CN106420619A
|
|
Drug ceftazidime dry suspension for treating surgery infection
|
CN106432279A
|
|
Method for preparing medicine ceftriaxone sodium crystal compound for treating surgical infection
|
CN106432281A
|
|
Preparation method of pharmaceutical ceftazidime crystal compound for treating surgical infection
|
CN106432282A
|
|
Preparation method of ceftazidime crystal compound for treating surgical infection
|
CN106432271A
|
|
Pharmaceutical ceftibuten crystal compound for treating surgical infection
|
CN106420760A
|
|
Ceftibuten pharmaceutical composition for treating surgical infection
|
CN106432272A
|
|
Method for preparing drug ceftibuten crystal compound for treating surgical operation infection
|
CN106432275A
|
|
Method for preparing crystalline ceftriaxone sodium compound as drug for treating surgical infection
|
CN106420617A
|
|
Medicine ceftibuten powder injection for treating surgical infection
|